DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Homolak J, Kodvanj I.
Widely available lysosome targeting agents should be considered as potential
therapy for COVID-19.
Int J Antimicrob Agents 2020; 106044
DOI: 10.1016/j.ijantimicag.2020.106044.
We do not assume any responsibility for the contents of the web pages of other providers.